US Hemorrhoids Treatment market size was valued at USD 1.464 Billion in 2022. The US Hemorrhoids Treatment Market industry is projected to grow from USD 1.534 Billion in 2023 to USD 2.534 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.58% during the forecast period (2024 - 2032). Increasing prevalence of hemorrhoids and new approaches to treat hemorrhoids are driving the market growth.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The U.S. hemorrhoid treatment market is currently undergoing a significant expansion, primarily fueled by the rising prevalence of hemorrhoids and a multitude of contributing factors. According to the US Department of Health and Human Services, the total number of people suffering from hemorrhoids in the United States is estimated to be around 10.4 million, with 1 million new cases diagnosed each year. Hemorrhoids, characterized by the swelling of veins in the rectum and anus, have become a pervasive health concern in the United States. This increase in prevalence can be attributed to several key factors, including contemporary lifestyle choices and dietary habits. The modern sedentary way of life, often characterized by prolonged periods of sitting, coupled with diets lacking in essential dietary fiber, has made hemorrhoids a more common affliction.
In addition to awareness, ongoing research and development efforts have led to remarkable advancements in the field of hemorrhoid treatment. Minimally invasive procedures, innovative medications, and cutting-edge technologies have emerged as novel approaches to managing this condition. These advancements not only improve treatment outcomes but also contribute to the overall expansion of the market as patients and healthcare providers seek more effective and patient-friendly options. The availability of healthcare infrastructure and specialized medical professionals further catalyzes the market's growth. Access to healthcare facilities and clinics that offer hemorrhoid treatment options is essential for patients seeking relief from this condition.
Moreover, Patients grappling with hemorrhoids prioritize treatments that offer relief from the pain and discomfort associated with the condition, ultimately enhancing their quality of life. The market is further bolstered by the presence of Over the Counter (OTC) products, such as creams, ointments, and suppositories, which provide convenient and accessible solutions for individuals looking to manage mild hemorrhoid symptoms independently.
The US Hemorrhoids Treatment market segmentation, based on Type, includes External Hemorrhoids, Internal Hemorrhoids, and Prolapsed Hemorrhoids. The Internal Hemorrhoids segment is to hold the majority share in 2022 in the US Hemorrhoids Treatment market revenue. This is because of the aging population, there is an increasing prevalence of internal hemorrhoids, spurring demand for effective remedies. Heightened awareness and education contribute to a proactive approach among individuals seeking treatment. Advances in medical technologies and a trend favoring minimally invasive procedures, such as rubber band ligation and infrared coagulation, are shaping the landscape. Additionally, the availability of over-the-counter products underscores a broader market for self-management. Monitoring these trends will provide a comprehensive understanding of the evolving landscape of internal hemorrhoid treatments and their continued growth in the US.
The US Hemorrhoids Treatment market segmentation is based on a Treatment Type, that includes Surgical, and nonsurgical. The non-surgical segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is due to the rise of effective and convenient treatments, and the market's expansion is further supported by increased awareness, education, and the availability of over-the-counter products, creating a comprehensive landscape for managing hemorrhoids in the US.
The US Hemorrhoids Treatment market segmentation is based on a Specialist, that includes Proctologist, General Physician, Gastroenterologist, and Others. The Proctologist specialist segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is due to the prevalence of hemorrhoids rising, especially among an aging population, and the demand for specialized care provided by proctologists is escalating. These specialists contribute significantly to the market's expansion by offering tailored and effective treatments, utilizing their expertise in both surgical and nonsurgical interventions. The increasing awareness of the importance of seeking specialized medical advice for hemorrhoid management further reinforces the market's growth trajectory in the United States.
Figure 2: US HEMORRHOIDS TREATMENT MARKET, BY INDICATION, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The US Hemorrhoids Treatment market segmentation is based on end-user that Hospital & clinics, Ambulatory surgical centers, and Others. The hospital & clinics segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2024-2032. This is due to as the prevalence of hemorrhoids increases, these healthcare facilities serve as crucial hubs for diagnosis, treatment, and management. Specialized gastrointestinal units in hospitals and dedicated proctology services in clinics contribute significantly to the market's expansion.
The US hemorrhoid treatment market is growing due to a rising prevalence of hemorrhoids, particularly among an aging demographic, and the demand for effective treatments is increasing. The market's trajectory is shaped by advancements in medical technologies, a trend towards less invasive procedures, and the expertise of proctologist specialists. Additionally, hospitals and clinics play a crucial role in providing comprehensive care, offering a range of treatment options, and contributing significantly to the market's expansion. Increased awareness, education, and the availability of over-the-counter products further bolster the growth of the hemorrhoids treatment market, creating a dynamic landscape in the United States.
The US Hemorrhoids Treatment market is characterized by the presence of many players. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reached across the US with diverse Type portfolios. Companies such as Medtronic Plc (Ireland), Cook Medical, Pfizer Inc (US), Boston Scientific Corporation (US) are dominate the US Hemorrhoids Treatment market due to Type differentiation, financial stability, strategic services, and diversified regional presence. The players are focused on investing in extensive research and development as well. Furthermore, they adopt strategic growth initiatives, such as expansion, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.
One of the primary business strategies adopted by manufacturers in the US hemorrhoid treatment industry to benefit clients and expand the healthcare counseling market sector is to manufacture locally to reduce operating costs.
Key Companies in the US Hemorrhoids Treatment Market include
In June 2022, ProNova Partners (US), a mergers and acquisitions firm based in the United States, was permitted to assist in the sale of all rights to manufacture and sell a patented, painless, non-invasive device to eliminate hemorrhoids.
In June 2022, Medtronic (Ireland) announced the launch of its new hemorrhoid treatment device, the HET Bipolar System, which treats internal hemorrhoids in a gentle, non-surgical manner. The system delivers bipolar energy to the hemorrhoid tissue, which causes coagulation and subsequent necrosis.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 1.464 Billion |
| Market Size 2023 | USD 1.534 Billion |
| Market Size 2032 | USD 2.534 Billion |
| Compound Annual Growth Rate (CAGR) | 4.58% (2024-2032) |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2019 to 2021 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Treatment Type, Specialist, End User, and Region |
| Countries Covered | US |
| Key Companies Profiled | Medtronic Plc (Ireland), CONMED Corporation (US) Cook Medical (US), Pfizer Inc (US), Abbott Laboratories (US), Boston Scientific Corporation (US), Integra LifeSciences (US), Sklar Surgical Instruments (US) Privi Medical (US), Olympus Corporation (Japan) Â |
| Key Market Opportunities | ·      Innovation in hemorrhoid treatment devices ·      Consumer Awareness and Education |
| Key Market Dynamics | ·      Increasing prevalence of hemorrhoids ·      New approaches to treat hemorrhoids |
Frequently Asked Questions (FAQ) :
The US Hemorrhoids Treatment market is anticipated to reach 2.534 billion at a CAGR of 4.58% during the forecast period of 2023-2032.
The US Hemorrhoids Treatment market is expected to grow at a 4.58% CAGR during the forecast period from 2023 to 2030.
The key players include Medtronic Plc (Ireland), CONMED Corporation (US) Cook Medical (US), Pfizer Inc (US), Abbott Laboratories (US), Boston Scientific Corporation (US), Integra LifeSciences (US), Sklar Surgical Instruments (US) Privi Medical (US), Olympus Corporation (Japan).
The Proctologist segment was estimated to lead the US hemorrhoid treatment market.
The Hospitals and clinics segment is attributed to having the largest market share based on end user.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
